Searchable abstracts of presentations at key conferences in endocrinology

ea0049oc6.5 | Diabetes therapy and complications | ECE2017

Activation of the Renin-Angiotensin II-Aldosterone-System leads to increases in extracellular protein disulfide isomerase: role in insulin resistance

Perez-Fuentes Ricardo , Pulido Patricia , Cazares Joshua , Inostroza-Nieves Yaritza , Torres-Rasgado Enrique , Nishiyama Akira , Rivera Alicia , Ortiz Rudy , Romero Jose

Insulin resistance and type II diabetes (T2D) are associated with activation of the Renin-Angiotensin-Aldosterone-System (RAAS) in part via regulation of its principal effector molecule, Angiotensin II (AngII). Endothelial cell activation leads to, among other factors, increased extracellular protein disulfide isomerase (PDI), a multifunctional protein that is critical to thrombus formation and regulation of reactive oxygen species. However, the effects of RAAS on PDI are unkn...

ea0049gp84 | Diabetes & complications 2 | ECE2017

Antidiabetic medication use and the risk of fracture in type 2 diabetic patients: a nested case-control study

Losada Eladio , Soldevila Berta , Ali M. Sanni , Martinez-Laguna Daniel , Nogues Xavier , Diez-Perez Adolfo , Puig-Domingo Manel , Mauricio Didac , Prieto-Alhambra Daniel

Background: Patients with type 2 diabetes mellitus (T2DM) have an increased risk of fragility fractures. Anti-diabetic oral agents and insulin may also impact on fracture risk. There is however scarce data available on the effect of such therapies combined as usually prescribed in real-life practice conditions.Objectives: The objective of this study was to compare the risk of fracture among T2DM patients who are users of different antidiabetic treatments...

ea0049gp128 | Endocrine Tumours | ECE2017

Peptides derived from the sst5TMD4 extracellular domain increase malignancy of endocrine-related cancer cells

Gahete Manuel D , Rio-Moreno Mercedes del , Alors-Perez Emilia , de Souza Patricia Borges , Prados-Gonzalez Maria E , Castano Justo P , Luque Raul M

A growing number of studies suggest that extracellular fragments derived from plasma membrane receptors can play relevant functional roles in the development and progression of certain tumoral pathologies which might, therefore, serve as novel tools in the diagnostic and prognostic of such pathologies. In this scenario, the truncated somatostatin receptor sst5TMD4, which is overexpressed in various endocrine-related cancers (i.e. breast, prostate, neuroendocrine, liver and pit...

ea0049gp235 | Thyroid Cancer | ECE2017

Clinical Utility of response to therapy in combination with BRAF in risk assessment of thyroid cancer

Fernandez Laura Perez , De la Vieja Escolar Antonio , Zafon Carles , Galofre Juan Carlos , Riesco-Eizaguirre Garcilaso , Spanish Task Force for the study of BRAF SEEN Garcilaso

Response to therapy re-stratification approach has been recently included in the 2015 ATA guidelines as a risk-adapted approach to management of thyroid cancer. Our aim was to investigate the clinical utility of response to therapy variables obtained during early follow-up in combination with BRAF, a prominent oncogene in thyroid cancer with prognostic value. This was a retrospective multicenter study of 871 patients at 11 centers in Spain with papillary thyroid cancer followe...

ea0049ep193 | Endocrine tumours and neoplasia | ECE2017

Short-term contralateral recurrence of a Litynski–Conn adenoma

Kuzior Agnieszka , Nivelo-Rivadeneira Manuel , Delia Santana-Suarez Ana , Arnas-Leon Claudia , Acosta-Calero Carmen , Quintana-Arroyo Sara , Martin-Perez Marta , Javier Martinez-Martin Francisco

Clinical Case: A hypertensive 60-year-old woman with nephroangiosclerotic stage IV chronic renal failure (eGFR 23.44 ml/min/1.73 m2) was referred to our hypertension clinic after the CT finding of a 26-mm left adrenal mass with adenoma density during hypertension workup, with normal right adrenal. Physical exam was unremarkable except for BP 167/98 mmHg. Plasma aldosterone was 353 ng/ml, PRA 1.3 ng/ml/h, ratio 90.2, K+3.1 mEq/l, and metanephrines were nor...

ea0049ep294 | Calcium & Vitamin D metabolism | ECE2017

Severe hypocalcemia induced by Denosumab in a patient with Osteroporosis after malabsorptive bariatric surgery

Portilla Ana Jimenez , Soler Guillermo Serra , Planella Juan Ramon Urgeles , Perez Maria Soledad Gogorza , Font Mercedes Noval , Fernandez Honorato Garcia , Jimenez Inaki Arguelles , Macazaga Vicente Pereg

Introduction: Denosumab is a monoclonal antibody indicated in the treatment of postmenopausal osteoporosis. Hypocalcemia is a rare adverse effect.Case report: We present the case of a 58-year-old woman with a clinical history of bariatric surgery in 2001 and osteoporosis with multiple vertebral and hip fractures. Under treatment with Zinc sulphate, Vitamin A, 25-OH-vitamin D, calcium and iron. She came to the A&E for general malaise, generalized weak...

ea0049ep390 | Clinical case reports - Thyroid/Others | ECE2017

Resistant hypertension in an obese type 2 diabetic male with obstructive sleep apnea: resolution with CPAP, weight loss and Dulaglutide

Arnas-Leon Claudia , Santana-Suarez Ana Delia , Rodriguez-Perez Alba , Nivelo-Rivadaneira Manuel , Kuzior Agnieszka , Quintana-Arroyo Sara , Acosta-Calero Carmen , Martinez-Martin Francisco Javier

A 49-year-old male was referred to our Hypertension Clinic with uncontrolled hypertension, treatment Valsartan/Amlodipine/Hydrochlorothiazide 80/10/25 mg + Doxazosine 4 mg. Mean home BP was 156/103 mmHg. Personal history: dyslipidaemia, central obesity and type 2 diabetes, with mild diabetic retinopathy, persistent microalbuminuria and preserved renal function. Treatment: Metformin/Sitagliptin 1000/50 mg BID; Pravastatin/Fenofibrate 40/160 mg. Height 172 cm, weight 112 kg, BMI...

ea0049ep472 | Diabetes (to include epidemiology, pathophysiology) | ECE2017

Dysregulation of the splicing machinery could represent an early, predictive event in the development of type 2 diabetes

Alors-Perez Emilia , Rio-Moreno Mercedes del , Pedraza-Arevalo Sergio , Camargo Antonio , Delgado-Lista Javier , Lopez-Miranda Jose , Gahete Manuel D , Castano Justo P , Luque Raul M

Metabolic syndrome (MetS) and type-2 diabetes (T2D) development is critically affected by the loss of phenotypic flexibility (i.e. the difficulty to cope with stressors to maintain metabolic homeostasis). Thus, it is essential to identify key modifiers of phenotypic plasticity that define individual susceptibility to develop T2D. Particularly, there is emerging evidence that alternative mRNA splicing is dysregulated under adverse metabolic-conditions, such as T2D, in several t...

ea0049ep869 | Clinical case reports - Pituitary/Adrenal | ECE2017

Coexistence of thyrotropinoma and chronic autoimmune thyroiditis, a diagnostic challenge

Olaizola Izaskun , Egana Nerea , Bilbao Ismene , de Ciriza Maite Perez , Antunano Maria Luisa , Elias Estela , Garcia Cristina , Aranburu Maite , Yoldi Alfredo , Goena Miguel Maria

Introduction: TSHomas are rare TSH producing tumors, whereas chronic autoimmune thyroiditis is a frequent condition. Patients with TSHoma are characterized by increased circulating levels of peripheral thyroid hormones, but when a chronic autoimmune thyroiditis is associated, they may be normal or low, making the diagnosis challenging.Case report: A 55 year-old woman, with previous medical history of obesity and impaired fasting glucose, was diagnosed of...

ea0049ep900 | Neuroendocrinology | ECE2017

Hyponatremia predating the diagnosis of malignancy in oncological/hematological patients with SIADH

Crespo-Hernandez Irene , Cuesta-Hernandez Martin , Santiago-Perez Alejandro , Gomez-Hoyos Emilia , Ortola-Buigues Ana , Miguel-Novoa Paz de , Chafer-Vilaplana Joan , Calle-Pascual Alfonso , Runkle Isabelle

Introduction: Euvolemic hyponatremia (HN) caused by the Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) can predate a diagnosis of malignancy. It is thus essential to accurately diagnose the etiology of HN/SIADH when detected.Methods: Retrospective, descriptive study of all 52 oncological/hematological malignancy patients diagnosed with SIADH in our Department between January 2011 and December 2016. HN was detected via computerized Prima...